Relmada Therapeutics Inc (RLMD)
3.68
-0.04
(-1.08%)
USD |
NASDAQ |
May 03, 16:00
3.66
-0.02
(-0.54%)
After-Hours: 20:00
Relmada Therapeutics Total Assets (Quarterly): 97.55M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 97.55M |
| September 30, 2023 | 109.15M |
| June 30, 2023 | 122.04M |
| March 31, 2023 | 135.57M |
| December 31, 2022 | 152.91M |
| September 30, 2022 | 187.12M |
| June 30, 2022 | 215.77M |
| March 31, 2022 | 225.81M |
| December 31, 2021 | 223.33M |
| September 30, 2021 | 90.93M |
| June 30, 2021 | 110.77M |
| March 31, 2021 | 103.87M |
| December 31, 2020 | 118.19M |
| September 30, 2020 | 125.60M |
| June 30, 2020 | 134.56M |
| March 31, 2020 | 115.42M |
| September 30, 2019 | 8.514M |
| June 30, 2019 | 10.22M |
| March 31, 2019 | 2.604M |
| December 31, 2018 | 3.299M |
| September 30, 2018 | 1.556M |
| June 30, 2018 | 3.048M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.796M |
| December 31, 2017 | 6.574M |
| September 30, 2017 | 5.614M |
| June 30, 2017 | 2.837M |
| March 31, 2017 | 4.170M |
| December 31, 2016 | 6.225M |
| September 30, 2016 | 7.922M |
| June 30, 2016 | 10.24M |
| March 31, 2016 | 12.72M |
| December 31, 2015 | 16.60M |
| September 30, 2015 | 20.48M |
| June 30, 2015 | 24.39M |
| March 31, 2015 | 27.85M |
| December 31, 2014 | 32.79M |
| September 30, 2014 | 27.85M |
| February 28, 2014 | 0.01M |
| November 30, 2013 | 0.0123M |
| August 31, 2013 | 0.02M |
| May 31, 2013 | 0.0047M |
| February 28, 2013 | 0.0102M |
| August 31, 2012 | 0.0184M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.514M
Minimum
Sep 2019
225.81M
Maximum
Mar 2022
127.07M
Average
120.11M
Median
Total Assets (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.805M |
| Lifecore Biomedical Inc | 255.15M |
| Harrow Inc | 312.16M |
| Corvus Pharmaceuticals Inc | 45.55M |
| Aquestive Therapeutics Inc | 57.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.19M |
| Shareholders Equity (Quarterly) | 85.36M |